OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plumbagin downregulates UHRF1, p-Akt, MMP-2 and suppresses survival, growth and migration of cervical cancer CaSki cells
Harsimran Sidhu, Neena Capalash
Toxicology in Vitro (2022) Vol. 86, pp. 105512-105512
Closed Access | Times Cited: 13

Showing 13 citing articles:

Unlocking the potential of 1,4-naphthoquinones: A comprehensive review of their anticancer properties
Eduardo Angulo-Elizari, Andreina Henriquez-Figuereo, Cristina Morán-Serradilla, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116249-116249
Open Access | Times Cited: 11

Advances in autophagy modulation of natural products in cervical cancer
Tao Tao, Ping Zhang, Zhi Zeng, et al.
Journal of Ethnopharmacology (2023) Vol. 314, pp. 116575-116575
Closed Access | Times Cited: 15

Prominent Naturally Derived Oxidative-Stress-Targeting Drugs and Their Applications in Cancer Treatment
Eunsun Lee, Dongki Yang, Jeong Hee Hong
Antioxidants (2025) Vol. 14, Iss. 1, pp. 49-49
Open Access

Plumbagin as a preferential lead molecule to combat EGFR-driven matrix abundance and migration of cervical carcinoma cells
Sneha Krishnamoorthy, Rajalakshmi Sabanayagam, Loganayaki Periyasamy, et al.
Medical Oncology (2024) Vol. 41, Iss. 4
Closed Access | Times Cited: 3

Pharmacological Features and Therapeutic Implications of Plumbagin in Cancer and Metabolic Disorders: A Narrative Review
Bhoomika Sharma, Chitra Dhiman, Gulam Mustafa Hasan, et al.
Nutrients (2024) Vol. 16, Iss. 17, pp. 3033-3033
Open Access | Times Cited: 2

Exploring natural resources: Plumbagin as a potent anticancer agent
Iftikhar Ahmad, Shams Tabrez
South African Journal of Botany (2024) Vol. 174, pp. 167-179
Closed Access | Times Cited: 2

Biological Potential of Carnivorous Plants from Nepenthales
Magdalena Wójciak, Marcin Feldo, Piotr Stolarczyk, et al.
Molecules (2023) Vol. 28, Iss. 8, pp. 3639-3639
Open Access | Times Cited: 6

Plumbagin induces apoptosis, cell cycle arrest, and inhibits protein synthesis in LoVo colon cancer cells: A proteomic analysis
Jianlong Shu, Richard C. Wang, Danya Zhao, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 5, pp. 1075-1084
Closed Access | Times Cited: 3

Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1
Waseem Ashraf, Tanveer Ahmad, Nicolas Reynoird, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 5997-5997
Open Access | Times Cited: 3

A comparative analysis of phyto-components on EGFR binding, viability, and migration in HPV positive ME180 and HPV negative C33A cervical cancer cells
Rajalakshmi Sabanayagam, Sneha Krishnamoorthy, Mohan Anbuselvam, et al.
Medical Oncology (2023) Vol. 40, Iss. 12
Closed Access | Times Cited: 3

The phytochemical plumbagin: mechanism behind its “pleiotropic” nature and potential as an anticancer treatment
Shikshya Swarupa Panda, Bijesh K. Biswal
Archives of Toxicology (2024)
Closed Access

Page 1

Scroll to top